IE45241B1 - Benz ( )-isoquinoline derivatives and their preparation - Google Patents

Benz ( )-isoquinoline derivatives and their preparation

Info

Publication number
IE45241B1
IE45241B1 IE1382/77A IE138277A IE45241B1 IE 45241 B1 IE45241 B1 IE 45241B1 IE 1382/77 A IE1382/77 A IE 1382/77A IE 138277 A IE138277 A IE 138277A IE 45241 B1 IE45241 B1 IE 45241B1
Authority
IE
Ireland
Prior art keywords
formula
compound
carbon atoms
stated
alkyl
Prior art date
Application number
IE1382/77A
Other languages
English (en)
Other versions
IE45241L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH863276A external-priority patent/CH622783A5/de
Priority claimed from CH863176A external-priority patent/CH622782A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE45241L publication Critical patent/IE45241L/xx
Publication of IE45241B1 publication Critical patent/IE45241B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1382/77A 1976-07-06 1977-07-04 Benz ( )-isoquinoline derivatives and their preparation IE45241B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH863276A CH622783A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives
CH863176A CH622782A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives

Publications (2)

Publication Number Publication Date
IE45241L IE45241L (en) 1978-01-06
IE45241B1 true IE45241B1 (en) 1982-07-14

Family

ID=25703556

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1382/77A IE45241B1 (en) 1976-07-06 1977-07-04 Benz ( )-isoquinoline derivatives and their preparation

Country Status (19)

Country Link
US (1) US4150136A (enExample)
JP (1) JPS537681A (enExample)
AT (1) AT366369B (enExample)
CA (1) CA1094561A (enExample)
DE (1) DE2728831A1 (enExample)
DK (1) DK285077A (enExample)
ES (2) ES460371A1 (enExample)
FI (1) FI65242C (enExample)
FR (1) FR2357547A1 (enExample)
GB (1) GB1582783A (enExample)
IE (1) IE45241B1 (enExample)
IL (1) IL52449A (enExample)
MY (1) MY8400058A (enExample)
NL (1) NL7707307A (enExample)
NZ (1) NZ184547A (enExample)
PH (1) PH14074A (enExample)
PT (1) PT66758B (enExample)
SE (2) SE7707445L (enExample)
SU (1) SU692559A3 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325803A (en) * 1964-10-01 1967-06-13 Ibm Deflection control circuit

Also Published As

Publication number Publication date
IL52449A (en) 1981-09-13
FI771986A7 (enExample) 1978-01-07
SU692559A3 (ru) 1979-10-15
DE2728831A1 (de) 1978-01-19
PT66758A (fr) 1977-08-01
AT366369B (de) 1982-04-13
MY8400058A (en) 1984-12-31
SE7707445L (sv) 1978-01-07
NZ184547A (en) 1980-08-26
GB1582783A (en) 1981-01-14
NL7707307A (nl) 1978-01-10
CA1094561A (en) 1981-01-27
PH14074A (en) 1981-01-26
PT66758B (fr) 1979-03-12
SE8207394L (sv) 1982-12-23
FI65242C (fi) 1984-04-10
FI65242B (fi) 1983-12-30
SE8207394D0 (sv) 1982-12-23
ATA477577A (de) 1981-08-15
ES460371A1 (es) 1979-05-01
IL52449A0 (en) 1977-10-31
FR2357547A1 (fr) 1978-02-03
JPS537681A (en) 1978-01-24
US4150136A (en) 1979-04-17
IE45241L (en) 1978-01-06
FR2357547B1 (enExample) 1980-02-15
ES476889A1 (es) 1979-07-16
AU2677177A (en) 1979-01-11
DK285077A (da) 1978-01-07

Similar Documents

Publication Publication Date Title
US3853915A (en) 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones
US4110337A (en) Triazolobenzodiazepines
EP0096838B1 (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines, a process for preparing the same and their use as medicaments
IE42216B1 (en) Benzomorphane derivatives
US4434171A (en) Dibenzazepine derivatives, pharmaceutical compositions containing them, and pharmaceutical methods using them
US3717641A (en) Derivatives of dibenzo cycloocten-5,11-imine
CA1086315A (en) Morphanthridine derivatives
US3408353A (en) 1, 3, 4, 9b-tetrahydro-2h-indeno(1, 2-c)pyridine derivatives
CA1317938C (en) Benzazapin derivatives
US4094987A (en) 2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)-ethanols
US4473573A (en) N-(2-methoxyethyl)-noroxymorphone and pharmaceutical compositions for relieving pain containing same
US3518271A (en) 1,2,3,4,4a,5,6,7,8,13 - decahydro - 7,13b - methano - 13bh - indolo(3,2-e)(2)benzazocines and process for their production
US4208420A (en) New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications
JPH0686435B2 (ja) ベンズアゼピン誘導体
IE45241B1 (en) Benz ( )-isoquinoline derivatives and their preparation
GB1596170A (en) 1,2,3,4,4a,10b-hexahydro-benz(f)isouqinolines
US3086972A (en) Aza-thiaxanthene derivatives
US3729465A (en) Hexahydroazepines
US4841056A (en) Substituted hexahydro-4H-indolo[6,5,4-cd]indoles
US4171366A (en) 1-Naphthothienylalkyl-1H-imidazoles
US4235903A (en) 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US3635962A (en) 4 - bis-morpholino- and 2
US3737544A (en) Compositions and methods utilizing 2,5-dimethyl-1,3,4,9b-tetrahydo-2h-indeno (1,2-c)pyridine
US4085102A (en) 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines
US3592816A (en) N-substituted piperazides of lysergic acid